Stephen Saad (born 23rd June 1964 in Durban) is a South African businessman and the founder and chief executive of Aspen Pharmacare.
His company is the largest producer of generic medicines in Africa.
Stephen Saad Age
He was born on the 23rd of June 1964 in Durban, South Africa. As of 2018, he is 55 years old.
Stephen Saad Wife
The name of his wife is not known but he is married with four daughters.
Johannesburg, South Africa – Pharmacare – Aspen Pharmacare
Healthcare Park, Woodlands Drive
+27 11 239 6100
Stephen Saad Awards
- 2014: He was awarded an honorary doctorate from Nelson Mandela Metropolitan University for the positive role of Aspen in the city of Port Elizabeth
- Convocation Award, University of KwaZulu-Natal
- South African Chapter of the World Entrepreneur Award, Ernst & Young
Stephen Saad Net Worth
At the age of 29, he became a millionaire when he sold his share in the drug business Covan Zurich for $3 million. He was worth US$640 million in 2011, therefore becoming one of Africa’s 40 richest people.
In 2013, his stock portfolio went up 75% and is worth US$1.4 billion. As of 2018, he was worth US$1.09 billion according to Forbes making him one of the richest men in South Africa.
Stephen Saad News
The All Africa Business Leaders Awards (AABLA) hosted in partnership with CNBC Africa and Forbes Africa honour remarkable leadership and salute game changers of business on the continent for their continuing commitment to excellence, developing best practices and innovative strategies.
As the founder of Aspen Pharmacare, Stephen Saad runs the continent’s largest pharmaceuticals maker and has now been crowned as Entrepreneur of the Year.
“You work at something and you build something together with the team and seldom have time to look back. To be recognized for it in this way is wonderful and particularly so for Aspen.”
“We are a company with roots in South Africa and manufacturing in South Africa. We’ve grown our local talent to become a world player and Aspen is just a wonderful South African story.” Stephen Saad said at the awards.
Saad, who is the founder of Aspen Pharmacare, Africa’s largest pharmaceuticals company, said that one of the biggest challenges he has faced recently was breaking into the generics market.
“Aspen competes with multinationals – we started a domestic company and have gone offshore to become a global company manufacturing in South Africa for domestic and export markets,” Saad said.
“Going forward we will continue to look for strategic partners. We have completed a number of significant transactions and Aspen has built a really strong foundation now. Our aspiration in the short term is to build on that base and to double our size.”